Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Mechanisms of resistance to CDK4/6 inhibitors in triple negative breast cancer

Dr Uzma Asghar - The Institute of Cancer Research, London, UK

Mechanisms of resistance to CDK4/6 inhibitors in triple negative breast cancer ( Dr Uzma Asghar - The Institute of Cancer Research, London, UK )

pSTAT3 in luminal breast cancer - results from BIG-2-98 trial

Dr Amir Sonnenblick - Hebrew University Medical Center, Jerusalem, Israel

pSTAT3 in luminal breast cancer - results from BIG-2-98 trial ( Dr Amir Sonnenblick - Hebrew University Medical Center, Jerusalem, Israel )

Increased long-term risk of breast cancer with high intra-tumour ER hetrogeneity

Dr Linda Lindström - University of California at San Francisco, San Francisco...

Increased long-term risk of breast cancer with high intra-tumour ER hetrogeneity ( Dr Linda Lindström - University of California at San Francisco, San Francisco, USA )

GTX-024 for androgen receptor positive breast cancer

Prof Beth Overmoyer - Dana-Farber Cancer Institute, Boston, USA

GTX-024 for androgen receptor positive breast cancer ( Prof Beth Overmoyer - Dana-Farber Cancer Institute, Boston, USA )

Adaptive trial design on breast cancer

Prof Laura Vant Veer - University of California San Francisco, San Francisco...

Adaptive trial design on breast cancer ( Prof Laura Vant Veer - University of California San Francisco, San Francisco, USA )

Identifying cancer in dense breast tissue

Cheryl Cruwys - Breast Density Matters UK

Identifying cancer in dense breast tissue ( Cheryl Cruwys - Breast Density Matters UK )

The molecular characterisation of oesophageal adenocarcinoma

Prof Rebecca Fitzgerald - University of Cambridge, Cambridge, UK

The molecular characterisation of oesophageal adenocarcinoma ( Prof Rebecca Fitzgerald - University of Cambridge, Cambridge, UK )

Centrosomes in ovarian cancer

Dr Fanni Gergely - CRUK Cambridge Institute

Centrosomes in ovarian cancer ( Dr Fanni Gergely - CRUK Cambridge Institute )

Hallmarks of cancer cell development

Dr Douglas Hanahan - Swiss Institute for Experimental Cancer Research, Lausanne...

Hallmarks of cancer cell development ( Dr Douglas Hanahan - Swiss Institute for Experimental Cancer Research, Lausanne, Switzerland )

Pembrolizumab and indoximod for melanoma

Prof Yousef Nabih Zakharia - Holden Comprehensive Cancer Center, University of...

Pembrolizumab and indoximod for melanoma ( Prof Yousef Nabih Zakharia - Holden Comprehensive Cancer Center, University of Iowa, Iowa City, USA )

Projections of cancer incidence and burden among the HIV-positive population in...

Jessica Yasmine Islam - University of North Carolina, Chapel Hill, USA

Projections of cancer incidence and burden among the HIV-positive population in the United States through 2030 ( Jessica Yasmine Islam - University of North Carolina, Chapel Hill, USA )

Nivolumab for NSCLC: five years on

Prof Julie Brahmer - Sidney Kimmel Comprehensive Cancer Center, Baltimore, USA

Nivolumab for NSCLC: five years on ( Prof Julie Brahmer - Sidney Kimmel Comprehensive Cancer Center, Baltimore, USA )

More from ecancer